Chatham Capital Group Inc. Has $1.43 Million Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

Chatham Capital Group Inc. grew its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,765 shares of the company’s stock after acquiring an additional 825 shares during the quarter. Chatham Capital Group Inc. owned 0.13% of U.S. Physical Therapy worth $1,430,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Point72 Asset Management L.P. bought a new position in shares of U.S. Physical Therapy during the fourth quarter worth $18,886,000. Bahl & Gaynor Inc. raised its stake in U.S. Physical Therapy by 135.4% during the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock worth $23,076,000 after buying an additional 149,622 shares during the period. Raymond James Financial Inc. bought a new position in U.S. Physical Therapy during the fourth quarter worth about $6,240,000. Nuveen Asset Management LLC lifted its holdings in shares of U.S. Physical Therapy by 95.9% during the 4th quarter. Nuveen Asset Management LLC now owns 120,893 shares of the company’s stock valued at $10,724,000 after purchasing an additional 59,190 shares in the last quarter. Finally, Envestnet Asset Management Inc. increased its stake in U.S. Physical Therapy by 20.1% during the 4th quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company’s stock worth $26,594,000 after purchasing an additional 50,163 shares in the last quarter.

Insider Activity at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.00% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JPMorgan Chase & Co. decreased their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, March 19th. Barrington Research dropped their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating on the stock in a research report on Friday, February 28th. Wall Street Zen raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Thursday, May 8th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $109.00.

U.S. Physical Therapy Stock Performance

Shares of NYSE USPH opened at $74.55 on Thursday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The stock has a 50 day moving average price of $72.12 and a 200 day moving average price of $82.37. The stock has a market capitalization of $1.13 billion, a PE ratio of 79.31, a price-to-earnings-growth ratio of 3.54 and a beta of 1.44. U.S. Physical Therapy, Inc. has a 52 week low of $62.77 and a 52 week high of $101.20.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to analysts’ expectations of $176.78 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm’s revenue was up 18.0% on a year-over-year basis. During the same period last year, the business earned $0.51 earnings per share. Analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Friday, May 23rd will be issued a $0.45 dividend. The ex-dividend date is Friday, May 23rd. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.41%. U.S. Physical Therapy’s payout ratio is 82.57%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.